[1] Timmers M, et al. Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, apotentoral BACE inhibitor.Alzheimers Dement (N Y).2016 Aug 24;2(3):202-212. DOI:
10.1016/j.trci.2016.08.001[2] Janssens J, et al. Passive immunotherapy with a novel antibody against 3pE-modified Aβ demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice. Neurobiol Dis. 2021 Jul;154:105365. DOI:
10.1016/j.nbd.2021.105365